European Journal of Microbiology and Immunology
Volume/Issue:
Volume 2: Issue 4
Tbnet — Collaborative research on tuberculosis in Europe
Authors:
C. Giehl European Research and Project Office GmbH — Eurice, Saarbrücken, Germany

Search for other papers by C. Giehl in
Current site
Google Scholar
PubMed Close
,
Christoph Lange Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany

Search for other papers by Christoph Lange in
Current site
Google Scholar
PubMed Close
,
R. Duarte Departmento de Epidemiologia Clinica, Medicina Preventiva e Saúde Pública Faculdade de Medicina da Universidade do Porto, Porto, Portugal

Search for other papers by R. Duarte in
Current site
Google Scholar
PubMed Close
,
G. Bothamley Department of Respiratory Medicine, Homerton University Hospital, London, UK

Search for other papers by G. Bothamley in
Current site
Google Scholar
PubMed Close
,
C. Gerlach Tuberculosis Network European Trialsgroup Office, Borstel, Germany

Search for other papers by C. Gerlach in
Current site
Google Scholar
PubMed Close
,
D. M. Cirillo Emerging Pathogens Unit, TB Supranational Reference Laboratory, San Raffaele Scientific Institute, Milano, Italy

Search for other papers by D. M. Cirillo in
Current site
Google Scholar
PubMed Close
,
D. Wagner Centre for Infectious Diseases and Travel Medicine and Centre for Chronic Immunodeficiency, University of Freiburg, Freiburg, Germany

Search for other papers by D. Wagner in
Current site
Google Scholar
PubMed Close
,
B. Kampmann Academic Department of Paediatrics, Imperial College, London, UK

Search for other papers by B. Kampmann in
Current site
Google Scholar
PubMed Close
,
D. Goletti Translational Research Unit, National Institute for Infectious Diseases, Rome, Italy

Search for other papers by D. Goletti in
Current site
Google Scholar
PubMed Close
,
T. Juers Betriebs- und Steuerberatungsgesellschaft SHBB mbH, Bad Oldesloe, Germany

Search for other papers by T. Juers in
Current site
Google Scholar
PubMed Close
, and
M. Sester Department of Transplant and Infection Immunology, Saarland University, Homburg, Germany

Search for other papers by M. Sester in
Current site
Google Scholar
PubMed Close
Pages:
264–274
Online Publication Date:
01 Dec 2012
Publication Date:
01 Dec 2012
Article Category:
Review Article
DOI:
https://doi.org/10.1556/eujmi.2.2012.4.4
Keywords:
Mycobacterium tuberculosis ; TBNET; NTM-NET; ptbnet; tuberculosis; Tuberculosis Network European Trialsgroup
Restricted access

Abstract

Networking is a key feature of scientific success. The Tuberculosis Network European Trialsgroup (TBNET) was founded in 2006 as a non-profit, non-governmental peer-initiated scientific organization to collaboratively address research priorities in the area of tuberculosis in Europe. Today, TBNET is the largest tuberculosis research organization in Europe with nearly 500 members from 22 EU countries and 49 countries worldwide (www.tb-net.org). Apart from small multicenter basic research studies, a particular strength of TBNET is the performance of large collaborative projects, pan-European multicenter studies and database projects. In recent years, research from TBNET has substantially contributed to the understanding of the management, risk and prognosis of patients with multidrug (MDR) and extensively drug-resistant (XDR) tuberculosis and led to a better understanding of the clinical value of novel tests for the identification of adults and children with tuberculosis and latent infection with Mycobacterium tuberculosis. In 2009, two branches of TBNET were founded to specifically address tuberculosis in the pediatric population (ptbnet) and non-tuberculous mycobacterial diseases (NTM-NET). In addition to the research activities, TBNET is developing expert consensus documents for clinical management and provides training and capacity building especially for members from Eastern European countries, where tuberculosis is still a prevalent health problem.

  • 1. WHO. 2011. Global Tuberculosis Control report. Geneva, Switzerland.

  • 2. M. Losi et al.2007 Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy Eur Respir J 30 1173–1179.

  • 3. G.B. Migliori et al.2007 Clinical and operational value of the extensively drug-resistant tuberculosis definition Eur Respir J 30 623–626.

    • Search Google Scholar
    • Export Citation

  • 4. G.B. Migliori et al.2007 Extensively drug-resistant tuberculosis, Italy and Germany Emerg Infect Dis 13 780–782.

  • 5. M. Ruhwald et al.2008 Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis Eur Respir J 32 1607–1615.

    • Search Google Scholar
    • Export Citation

  • 6. D. Goletti et al.2008 Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study PLoS ONE 3 e3417.

    • Search Google Scholar
    • Export Citation

  • 7. C. Jafari et al.2009 Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study Am J Respir Crit Care Med 180 666–673.

    • Search Google Scholar
    • Export Citation

  • 8. M. Ruhwald et al.2011 A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis Tuberculosis (Edinb) 91 260–267.

    • Search Google Scholar
    • Export Citation

  • 9. R. Basu Roy et al.2012 Identifying predictors of interferon-gamma release assay results in pediatric latent tuberculosis: a protective role of bacillus calmette-guerin?: a pTB-NET Collaborative Study Am J Respir Crit Care Med 186 378–384.

    • Search Google Scholar
    • Export Citation

  • 10. A.R. Bamford et al.2010 Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study Arch Dis Child 95 180–186.

    • Search Google Scholar
    • Export Citation

  • 11. B. Eker et al.2008 Multidrug- and extensively drug-resistant tuberculosis, Germany Emerg Infect Dis 14 1700–1706.

  • 12. G.B. Migliori et al.2009 MDR-TB and XDR-TB: drug resistance and treatment outcomes Eur Respir J 34 778–779.

  • 13. G.B. Migliori et al.2008 Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results Clin Infect Dis 46 958–959.

    • Search Google Scholar
    • Export Citation

  • 14. G.B. Migliori et al.2008 Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? Eur Respir J 31 904–905.

  • 15. G.B. Migliori et al.2008 Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases Eur Respir J 31 1155–1159.

    • Search Google Scholar
    • Export Citation

  • 16. Sotgiu G et al.: Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J, erj00229 (2012).

    • Search Google Scholar
    • Export Citation

  • 17. G.B. Migliori et al.2012 TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Eur Respir J 39 619–625.

    • Search Google Scholar
    • Export Citation

  • 18. G. Sotgiu et al.2010 Development of a standardised tool to survey MDR-/XDR-TB case management in Europe Eur Respir J 36 208–211.

  • 19. M. Sester et al.2011 Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and metaanalysis Eur Respir J 37 100–111.

    • Search Google Scholar
    • Export Citation

  • 20. R. Diel et al.2011 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis Eur Respir J 37 88–99.

    • Search Google Scholar
    • Export Citation

  • 21. U. Mack et al.2009 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Eur Respir J 33 956–973.

    • Search Google Scholar
    • Export Citation

  • 22. C.G. Erkens et al.2010 Tuberculosis contact investigation in low prevalence countries: a European consensus Eur Respir J 36 925–949.

  • 23. I. Solovic et al.2010 The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Eur Respir J 36 1185–1206.

    • Search Google Scholar
    • Export Citation

  • 24. Bumbacea D et al.: The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J, in press (2012).

    • Search Google Scholar
    • Export Citation

  • 25. G.B. Migliori et al.2012 European union standards for tuberculosis care Eur Respir J 39 807–819.

  • 26. T.S. Jordan D. Cullen P.D. Davies 2012 A centralised electronic Multidrug-Resistant Tuberculosis Advisory Service: the first 2 years Int J Tuberc Lung Dis 16 950–954.

    • Search Google Scholar
    • Export Citation

  • 27. C. Dye B.G. Williams 2010 The population dynamics and control of tuberculosis Science 328 856–861.

  • 28. Smieja MJ et al.: Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev, CD001363 (2000).

  • 29. Bothamley G , Ruhwald M, Goletti D: Omics and single molecule detection: the future of tuberculosis diagnostics. Eur Respir Monograph, in press (2012).

    • Search Google Scholar
    • Export Citation
  • Collapse
  • Expand
Cover European Journal of Microbiology and Immunology
European Journal of Microbiology and Immunology
Print ISSN:
2062-509X
Online ISSN:
2062-8633
Submit Your Manuscript

 

The author instructions are available in PDF.
Please, download the file from HERE.

 

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita, Prof. Dr. Pharm, Dr. rer. nat., University of Magdeburg, Germany

Editor(s)-in-Chief: Heimesaat, Markus M., Prof. Dr. med., Charité - University Medicine Berlin, Germany

Editorial Board

  • Berit Bangoura, Dr. DVM. PhD,  University of Wyoming, USA
  • Stefan Bereswill, Prof. Dr. rer. nat., Charité - University Medicine Berlin, Germany
  • Dunja Bruder, Prof. Dr. rer. nat., University of Magdeburg, Germany
  • Jan Buer, Prof. Dr. med., University of Duisburg, Germany
  • Edit Buzas, Prof. Dr. med., Semmelweis University, Hungary
  • Renato Damatta, Prof. PhD, UENF, Brazil
  • Maria Deli, MD, PhD, DSc, Biological Research Center, HAS, Hungary
  • Olgica Djurković-Djaković, Prof. Phd, University of Belgrade, Serbia
  • Jean-Dennis Docquier, Prof. Dr. med., University of Siena, Italy
  • Zsuzsanna Fabry, Prof. Phd, University of Washington, USA
  • Ralf Ignatius, Prof. Dr. med., Charité - University Medicine Berlin, Germany
  • Achim Kaasch, Prof. Dr. med., Otto von Guericke University Magdeburg, Germany
  • Oliver Liesenfeld, Prof. Dr. med., Inflammatix, USA
  • Matyas Sandor, Prof. PhD, University of Wisconsin, USA
  • Ulrich Steinhoff, Prof. PhD, University of Marburg, Germany
  • Michal Toborek, Prof. PhD, University of Miami, USA
  • Susanne A. Wolf, PhD, MDC-Berlin, Germany

 

Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildiko.dunay@med.ovgu.de

Indexing and Abstracting Services:

  • PubMed Central
  • Scopus
  • ESCI
  • CABI
  • CABELLS Journalytics

 

2023  
Web of Science  
Total Cites
WoS		 674
Journal Impact Factor 3.3
Rank by Impact Factor

Q2
Impact Factor
without
Journal Self Cites		 3.1
5 Year
Impact Factor		 3.2
Scimago  
Scimago
H-index		 15
Scimago
Journal Rank		 0.601
Scimago Quartile Score Microbiology (medical) (Q2)
Microbiology (Q3)
Immunology and Allergy (Q3)
Immunology (Q3)
Scopus  
Scopus
Cite Score		 5.0
Scopus
CIte Score Rank		 Microbiology (medical) Q2
Scopus
SNIP		 0.832

 

European Journal of Microbiology and Immunology
Publication Model Gold Open Access
Online only
Submission Fee none
Article Processing Charge 600 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

European Journal of Microbiology and Immunology
Language English
Size A4
Year of
Foundation		 2011
Volumes
per Year		 1
Issues
per Year		 4
Founder Akadémiai Kiadó
Founder's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 2062-509X (Print)
ISSN 2062-8633 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Mar 2024 2 1 0
Apr 2024 43 0 0
May 2024 13 0 0
Jun 2024 9 0 0
Jul 2024 9 0 0
Aug 2024 39 0 0
Sep 2024 5 0 0